Prevention of CMV/EBV reactivation by double-specific T cells in patients after allogeneic stem cell transplantation: results from the randomized phase I/IIa MULTIVIR-01 study

INTRODUCTION: Allogeneic stem cell transplantation is used to cure hematologic malignancies or deficiencies of the hematopoietic system. It is associated with severe immunodeficiency of the host early after transplant and therefore early reactivation of latent herpesviruses such as CMV and EBV withi...

Descripción completa

Detalles Bibliográficos
Autores principales: Gerbitz, Armin, Gary, Regina, Aigner, Michael, Moosmann, Andreas, Kremer, Anita, Schmid, Christoph, Hirschbuehl, Klaus, Wagner, Eva, Hauptrock, Beate, Teschner, Daniel, Roesler, Wolf, Spriewald, Bernd, Tischer, Johanna, Moi, Stephanie, Balzer, Heidi, Schaffer, Stefanie, Bausenwein, Judith, Wagner, Anja, Schmidt, Franziska, Brestrich, Jens, Ullrich, Barbara, Maas, Stefanie, Herold, Susanne, Strobel, Julian, Zimmermann, Robert, Weisbach, Volker, Hansmann, Leo, Lammoglia-Cobo, Fernanda, Remberger, Mats, Stelljes, Matthias, Ayuk, Francis, Zeiser, Robert, Mackensen, Andreas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10642256/
https://www.ncbi.nlm.nih.gov/pubmed/37965339
http://dx.doi.org/10.3389/fimmu.2023.1251593

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10642256/
https://www.ncbi.nlm.nih.gov/pubmed/37965339
http://dx.doi.org/10.3389/fimmu.2023.1251593

Ejemplares similares